Download PDF

This activity is no longer available for credit, however its content is still (may still be) relevant for your educational needs.

Valid: March 4th, 2010 - March 4th, 2011

Target Audience
This activity was developed for physicians, nurses, pharmacists, and other healthcare professionals practicing in a managed care environment.

Educational Objectives
At the completion of this activity participants should be able to:

  • Outline the impact of DVT on patients and US healthcare stakeholders, as well as its economic burden on stakeholders, health plans, employers, hospitals, and long-term care facilities
  • Identify and describe the pathophysiology of DVT
  • Discuss guideline-based recommendations for the appropriate assessment and management of DVT
  • Assess the safety and efficacy of current treatment strategies used to diagnose and treat patients with DVT
  • Implement strategies to prevent residual DVT risk and implications in health plan participants


Estimated time to complete this activity: 1.0 hour

Physician Credit Designation
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Medical Education Resources, Inc. (MER), Medical Learning Institute, Inc. (MLI), and Center of Excellence Media, LLC. MER is accredited by the ACCME to provide continuing medical education for physicians.

Medical Education Resources designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Registered Nurse Designation
Medical Learning Institute, Inc.

Provider approved by the California Board of Registered Nursing, Provider Number 15106, for 1.0 contact hour.

Pharmacists Designation
MLI is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Completion of this activity provides for 1.0 contact hour (0.1 CEU) of continuing education credit. The universal program number for this activity is 0468-9999-10-010-H01-P.

Disclosure Statement
Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported, or used in a CME activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing its learners with high-quality CME activities that promote improvements or quality in health care and not the business interest of a commercial interest.

The faculty reported the following financial relationships with commercial interests whose products or services may be mentioned in this CME activity:

Name of Faculty
Reported Financial Relationship
John Fanikos, RPh, MBA Speaker's Bureau of sanofi-aventis
Speaker's Bureau of GlaxoSmithKline
Consultant to the Medicine Company
John A. Heit, MD Nothing to disclose

The content managers reported the following financial relationships with commercial interests whose products or services may be mentioned in this CME activity:

Name of Content Manager
Reported Financial Relationship
Victoria Smith, MD (MER) No financial relationships to disclose
Ryan Sims, CRNA, MS (MLI) No financial relationships to disclose
Judy Silman-Greenspan, RPh, MPharm Sci (MLI) No financial relationships to disclose

The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of MER, MLI, or Center of Excellence Media, LLC. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of MER, MLI, Center of Excellence Media, LLC, and sanofi-aventis. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.

Last modified: March 21, 2014